This content is from: Premium What Drove Greenlight’s Stellar Performance in 2022 A look under the hood reveals that shorting wasn’t the only reason why David Einhorn enjoyed his best year for delivering alpha. By Stephen Taub January 25, 2023
This content is from: Premium Citadel Posts Its Biggest Gain in Over a Decade Ken Griffin ran the top performing multistrategy fund in 2022. By Stephen Taub January 06, 2023
This content is from: Premium Citadel Added to Its 2022 Gains in September Most multistrats remain solidly in the black for the year. By Stephen Taub October 07, 2022
This content is from: Premium Citadel Stays Ahead of the Multistrat Pack Most of the prominent, well-known funds posted mixed results in November. By Stephen Taub December 07, 2022
Sponsored Atlas Genetics Raises £16.9M In VC Funding Infectious disease test development firm Atlas Genetics has raised £16.9 million in a Series B venture financing round. July 20, 2011
This content is from: Premium Greenlight Sidesteps September Swoon David Einhorn benefited heavily from his big Twitter bet. By Stephen Taub October 03, 2022
